Skip to main content

Olink: Analytical Validation (Mt Sinai)

BRD ID: 3113
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 7868

Description

This assay analytical validation and performance report describes the methods used to validate a Olink multiplex immunoassay (specifically using an Olink Immuno-Onc Kit with a Proseek Olink Proteomics platform on a Fluidigm Biomark HD microfluidic PCR machine) to analyze RNA expression of frozen plasma (EDTA, acid citrate dextrose (ACD), sodium heparin), serum, and bone marrow specimens. The document also presents data supporting the reported accuracy, precision, analytical sensitivity and specificity, reference intervals, detection limit, measuring range, high dose hook effect, and scalability. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at Mount Sinai. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).